Denver, CO (PRWEB) May 22, 2005
Dr. Mark E. Meaney, Executive Director, announced the formation of the Center for Health Care Ethics and Emerging Technologies on the Regis University campus in Denver. The purpose of the Center will be to promote international guidelines for the development of biotechnology, for example, nanobiotechnologies and stem cell research.
Dr. Meaney emphasized the need to establish standards since controversies continue to erupt due to a lack of international guidelines for biotechnology.
He cited the recent controversy generated by advances in stem cell research in South Korea. Dr. Meaney stated that, "Some see the ethics of cloning a human embryo as culturally relative; others see it as a matter that speaks directly to the human condition in general, which should not be left to cultural preferences."
This dispute is all the more urgent, said Dr. Meaney, because, for example, what happens in South Korea is of global import.
While health care professionals and national governments ought to have input, the origin of guidelines for emerging biotechnologies ought to be international and universal.
The Center for Health Care Ethics and Emerging Technologies will examine ways in which to transcend cultural relativism and establish global ethical standards.
Dr. Meaney anticipates that the challenge will be carefully to distinguish between cultural differences that warrant tolerance and violations of universal ethical standards that require international action in protecting victims of unethical behavior.
"The work of the Center for Health Care Ethics and Emerging Technologies on the Regis University campus will encourage research and dialogue to bridge differences in establishing international guidelines for the development of technologies that will benefit all," Dr. Meaney stated.
Mark E. Meaney, Ph.D.
Center For Health Care Ethics And Emerging Technologies